Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Repurposed Drugs
1.2 Key Market Segments
1.2.1 Repurposed Drugs Segment by Type
1.2.2 Repurposed Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Repurposed Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Repurposed Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Repurposed Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Repurposed Drugs Market Competitive Landscape
3.1 Global Repurposed Drugs Sales by Manufacturers (2019-2024)
3.2 Global Repurposed Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Repurposed Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Repurposed Drugs Sales Sites, Area Served, Product Type
3.6 Repurposed Drugs Market Competitive Situation and Trends
3.6.1 Repurposed Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Repurposed Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Repurposed Drugs Industry Chain Analysis
4.1 Repurposed Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Repurposed Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Repurposed Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Repurposed Drugs Sales Market Share by Type (2019-2024)
6.3 Global Repurposed Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Repurposed Drugs Price by Type (2019-2024)
7 Repurposed Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Repurposed Drugs Market Sales by Application (2019-2024)
7.3 Global Repurposed Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Repurposed Drugs Sales Growth Rate by Application (2019-2024)
8 Repurposed Drugs Market Segmentation by Region
8.1 Global Repurposed Drugs Sales by Region
8.1.1 Global Repurposed Drugs Sales by Region
8.1.2 Global Repurposed Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Repurposed Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Repurposed Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Repurposed Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Repurposed Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Repurposed Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Teva
9.1.1 Teva Repurposed Drugs Basic Information
9.1.2 Teva Repurposed Drugs Product Overview
9.1.3 Teva Repurposed Drugs Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Repurposed Drugs SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Novartis
9.2.1 Novartis Repurposed Drugs Basic Information
9.2.2 Novartis Repurposed Drugs Product Overview
9.2.3 Novartis Repurposed Drugs Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Repurposed Drugs SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Mylan
9.3.1 Mylan Repurposed Drugs Basic Information
9.3.2 Mylan Repurposed Drugs Product Overview
9.3.3 Mylan Repurposed Drugs Product Market Performance
9.3.4 Mylan Repurposed Drugs SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Repurposed Drugs Basic Information
9.4.2 Johnson and Johnson Repurposed Drugs Product Overview
9.4.3 Johnson and Johnson Repurposed Drugs Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Pfizer
9.5.1 Pfizer Repurposed Drugs Basic Information
9.5.2 Pfizer Repurposed Drugs Product Overview
9.5.3 Pfizer Repurposed Drugs Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Bausch Health
9.6.1 Bausch Health Repurposed Drugs Basic Information
9.6.2 Bausch Health Repurposed Drugs Product Overview
9.6.3 Bausch Health Repurposed Drugs Product Market Performance
9.6.4 Bausch Health Business Overview
9.6.5 Bausch Health Recent Developments
9.7 GSK
9.7.1 GSK Repurposed Drugs Basic Information
9.7.2 GSK Repurposed Drugs Product Overview
9.7.3 GSK Repurposed Drugs Product Market Performance
9.7.4 GSK Business Overview
9.7.5 GSK Recent Developments
9.8 ChemRar Group
9.8.1 ChemRar Group Repurposed Drugs Basic Information
9.8.2 ChemRar Group Repurposed Drugs Product Overview
9.8.3 ChemRar Group Repurposed Drugs Product Market Performance
9.8.4 ChemRar Group Business Overview
9.8.5 ChemRar Group Recent Developments
9.9 Glenmark
9.9.1 Glenmark Repurposed Drugs Basic Information
9.9.2 Glenmark Repurposed Drugs Product Overview
9.9.3 Glenmark Repurposed Drugs Product Market Performance
9.9.4 Glenmark Business Overview
9.9.5 Glenmark Recent Developments
9.10 Fujifilm
9.10.1 Fujifilm Repurposed Drugs Basic Information
9.10.2 Fujifilm Repurposed Drugs Product Overview
9.10.3 Fujifilm Repurposed Drugs Product Market Performance
9.10.4 Fujifilm Business Overview
9.10.5 Fujifilm Recent Developments
9.11 Dr. Reddy
9.11.1 Dr. Reddy Repurposed Drugs Basic Information
9.11.2 Dr. Reddy Repurposed Drugs Product Overview
9.11.3 Dr. Reddy Repurposed Drugs Product Market Performance
9.11.4 Dr. Reddy Business Overview
9.11.5 Dr. Reddy Recent Developments
9.12 R-Pharma
9.12.1 R-Pharma Repurposed Drugs Basic Information
9.12.2 R-Pharma Repurposed Drugs Product Overview
9.12.3 R-Pharma Repurposed Drugs Product Market Performance
9.12.4 R-Pharma Business Overview
9.12.5 R-Pharma Recent Developments
10 Repurposed Drugs Market Forecast by Region
10.1 Global Repurposed Drugs Market Size Forecast
10.2 Global Repurposed Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Repurposed Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Repurposed Drugs Market Size Forecast by Region
10.2.4 South America Repurposed Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Repurposed Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Repurposed Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Repurposed Drugs by Type (2025-2030)
11.1.2 Global Repurposed Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Repurposed Drugs by Type (2025-2030)
11.2 Global Repurposed Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Repurposed Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Repurposed Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
